KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Receivables (2016 - 2026)

AbbVie has reported Receivables over the past 14 years, most recently at $12.6 billion for Q4 2025.

  • Quarterly Receivables rose 15.29% to $12.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.6 billion through Dec 2025, up 15.29% year-over-year, with the annual reading at $12.6 billion for FY2025, 15.29% up from the prior year.
  • Receivables was $12.6 billion for Q4 2025 at AbbVie, down from $12.8 billion in the prior quarter.
  • Over five years, Receivables peaked at $12.8 billion in Q3 2025 and troughed at $9.3 billion in Q3 2021.
  • The 5-year median for Receivables is $11.3 billion (2022), against an average of $11.2 billion.
  • Year-over-year, Receivables soared 50.71% in 2021 and then decreased 2.12% in 2024.
  • A 5-year view of Receivables shows it stood at $10.0 billion in 2021, then increased by 12.8% to $11.3 billion in 2022, then fell by 0.88% to $11.2 billion in 2023, then fell by 2.12% to $10.9 billion in 2024, then rose by 15.29% to $12.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Receivables are $12.6 billion (Q4 2025), $12.8 billion (Q3 2025), and $12.6 billion (Q2 2025).